Cellular, serological, and molecular polymorphism of the class I and class II loci of the canine major histocompatibility complex

Tissue Antigens

Volumn 59, Issue 3, 2002, Pages 205-210

  Wagner, J L ^a,b,c,e   Sarmiento, U M ^a,d   Storb, R ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d PathoMetrix   (United States)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Canine major histocompatibility complex; Dog Leukocyte Antigen (DLA); Haplotype; Serology

Indexed keywords

HISTOCOMPATIBILITY ANTIGEN; LEUKOCYTE ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; HISTOCOMPATIBILITY ANTIGEN DLA; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2;

ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; DOG; GENE LOCUS; HETEROZYGOSITY; HOMOZYGOSITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MIXED LEUKOCYTE CULTURE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; ANIMAL; BLOOD GROUP TYPING; COMPARATIVE STUDY; GENE; GENETIC POLYMORPHISM; GENETICS; HISTOCOMPATIBILITY TEST; HOMOZYGOTE; IMMUNOLOGY; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

ANIMAL; BLOOD GROUPING AND CROSSMATCHING; COMPARATIVE STUDY; DOGS; GENES, MHC CLASS I; GENES, MHC CLASS II; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HISTOCOMPATIBILITY TESTING; HOMOZYGOTE; POLYMERASE CHAIN REACTION; POLYMORPHISM (GENETICS); SENSITIVITY AND SPECIFICITY; SUPPORT, U.S. GOV'T, P.H.S.; ANIMALS; POLYMORPHISM, GENETIC;

CANIS FAMILIARIS;

EID: 0035987535     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0039.2002.590304.x     Document Type: Article

References (29)

1. Canine model of narcolepsy: Genetic and developmental determinants
2. Hemophilia in dogs, with special reference to hemophilia A among German shepherd dogs in Denmark. I. Pathophysiology, laboratory tests and genetics
3. Development of wheat sensitive enteropathy in Irish setters: Morphological changes
4. Model systems of prostate cancer: Uses and limitations
5. Joint report of the third international workshop on canine immunogenetics. I. Analysis of homozygous typing cells
6. Joint report of the third international workshop on canine immunogenetics. II. Analysis of serological typing of cells
7. Molecular analysis of six dog leukocyte antigen (DLA) class I sequences including three complete genes, two truncated genes, and one full-length processed gene
8. Nucleotide sequence and polymorphism analysis of canine DRA cDNA clones
9. Molecular analysis of the DLA DR subregion
10. Molecular analysis and polymorphism of the DLA-DQA gene
11. Molecular analysis and polymorphism of DLA-DQB genes
12. Polymorphism analysis of four canine class I genes
13. Molecular analysis of DLA-DRBB1 polymorphism
14. Nine new dog DLA-DRB1 alleles identified by sequence based typing
15. Histocompatibility testing of dog families with polymorphic microsatellite markers
16. Nomenclature for the DLA system, 1998: First report of the ISAG DLA nomenclature committee
17. The canine major histocompatibility complex. Population study of DLA-D alleles using a panel of homozygous typing cells
18. DLA-DRBB1 and DLA-DQBC1 histocompatibility typing by PCR-SSCP and sequencing
19. Dog class I gene DLA-88 histocompatibility typing by PCR-SSCP and sequencing
20. Identification and characterization of a highly polymorphic microsatellite marker within the canine MHC Class I region
21. Nomenclature for factors of the dog histocompatibility system (DLA), 2000. Second report of the ISAG DLA Nomenclature Committee
22. HLA class II polymorphism: Implications for genetic susceptibility to autoimmune disease
23. Characterization of class II alpha genes and DLA-D region allelic associations in the dog
24. The canine major histocompatibility complex: Genetic structure and function of the NHC of dogs
25. Structural model for T-cell recognition of HLA class II associated alloepitopes
26. Position 71 in the alpha helix of the DR beta domain is predicted to influence peptide binding and plays a central role in allorecognition
27. Different regions of the N-terminal domains of HLA-DRB1 influence recognition of individual peptide -DR1 complexes
28. A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules
29. Limited regions of the alpha 2-domain alpha-helix control anti-A2 allorecognition: An analysis using a panel of A2 mutants